Mass Spectrometry Market
Mass Spectrometry Industry Insights and Strategic Analysis, 2030: Profiles the 12 Leading Players in the Forecasted $5.8 Billion Market
October 04, 2024 06:03 ET | Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Mass Spectrometry - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Mass...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
October 03, 2024 16:05 ET | Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Cytokinetics.png
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2024 16:00 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on September 30, 2024 it granted stock options to purchase an aggregate...
Portrait-Logo.jpg
ProductLife Group (PLG) Acquires Nextep to Further Expand its Global Patient Access Capabilities
October 03, 2024 03:00 ET | Groupe Product Life
ProductLife Group (PLG is pleased to announce the acquisition of Nextep, a reputed French consultancy specialized in market access and public affairs.
Reneo_Update_Inline_RGB_REGISTERED_OTL_GREY_TP.jpg
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
October 02, 2024 20:20 ET | Reneo Pharmaceuticals, Inc.
– Combined company to trade on Nasdaq under ticker “OKUR” – Reneo announces 1-for-10 reverse split of common stock IRVINE, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc....
Cytokinetics.png
Cytokinetics to Host Investor & Analyst Day on October 16, 2024
October 02, 2024 16:00 ET | Cytokinetics, Incorporated
Company Leadership to Discuss Cardiac Myosin Modulation, Specialty Cardiology Programs and Commercial Launch Preparations SOUTH SAN FRANCISCO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) --...
K4-MA-SE-TX-L1.jpg
Keiretsu Forum Announces Dr. Martin Gershon as Keynote Speaker for 2024 Investor Capital Expo
October 02, 2024 07:08 ET | Keiretsu Forum Mid-Atlantic
This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.
Biostem main logo .png
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
October 02, 2024 07:00 ET | BioStem Technologies, Inc.
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
ocugen_4C_LOGO (002).png
Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa
October 02, 2024 06:30 ET | Ocugen
MALVERN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
BioNTX StandardMed_Res.jpg
BioNTX Announces the 2024 Dennis K. Stone Award Recipient
October 01, 2024 10:48 ET | BioNTX
DALLAS, Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioNTX, the bioscience and healthcare innovation trade organization serving North Texas, is pleased to introduce D. Jeff Keyser, RPh, JD, PhD as the...